Related Experiment Videos
Peripheral opioid analgesia.
C Stein1, H Machelska, W Binder
1Department of Anesthesiology and Critical Care Medicine, Klinikum Benjamin Franklin, Freie Universität Berlin, Germany. cstein@medizin.fu-berlin.de
Current Opinion in Pharmacology
|November 20, 2001
Summary
Recent advances in peripheral opioid analgesia show reduced tolerance during inflammation and potent anti-inflammatory effects. Novel tetrapeptides and selectin roles in pain relief are highlighted, advancing chronic pain treatment.
Area of Science:
- Pharmacology
- Immunology
- Pain Research
Background:
- Peripheral opioid analgesia research is advancing rapidly.
- Understanding opioid interactions in inflammatory conditions is crucial for pain management.
Purpose of the Study:
- To summarize recent key findings in peripheral opioid analgesia.
- To highlight novel therapeutic strategies for chronic pain, particularly arthritis.
Main Methods:
- Review of recent research findings in peripheral opioid analgesia.
- Analysis of molecular mechanisms, including selectin involvement.
- Assessment of clinical studies in chronic arthritic pain.
Main Results:
- Peripheral opioid analgesia exhibits a relative lack of tolerance under inflammatory conditions.
- Tetrapeptides show promise as novel, peripherally restricted analgesic compounds.
- Mu and kappa agonists demonstrate potent anti-inflammatory activity.
- Selectins are identified as key molecules in opioid cell homing to injured tissues.
Conclusions:
- Peripheral opioid analgesia offers a promising avenue for managing inflammatory pain.
- Novel compounds and molecular targets are emerging for chronic pain treatment.
- Clinical translation for chronic arthritic pain is a significant development.